Mivacurium

Jump to: navigation, search
Mivacurium
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Mivacurium is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

There is limited information regarding Mivacurium FDA-Labeled Indications and Dosage (Adult) in the drug label.

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mivacurium in adult patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mivacurium in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

There is limited information regarding Mivacurium FDA-Labeled Indications and Dosage (Pediatric) in the drug label.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

There is limited information regarding Off-Label Guideline-Supported Use of Mivacurium in pediatric patients.

Non–Guideline-Supported Use

There is limited information regarding Off-Label Non–Guideline-Supported Use of Mivacurium in pediatric patients.

Contraindications

There is limited information regarding Mivacurium Contraindications in the drug label.

Warnings

There is limited information regarding Mivacurium Warnings' in the drug label.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Mivacurium Clinical Trials Experience in the drug label.

Postmarketing Experience

There is limited information regarding Mivacurium Postmarketing Experience in the drug label.

Drug Interactions

There is limited information regarding Mivacurium Drug Interactions in the drug label.

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA): There is no FDA guidance on usage of Mivacurium in women who are pregnant.
Pregnancy Category (AUS): There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Mivacurium in women who are pregnant.

Labor and Delivery

There is no FDA guidance on use of Mivacurium during labor and delivery.

Nursing Mothers

There is no FDA guidance on the use of Mivacurium in women who are nursing.

Pediatric Use

There is no FDA guidance on the use of Mivacurium in pediatric settings.

Geriatic Use

There is no FDA guidance on the use of Mivacurium in geriatric settings.

Gender

There is no FDA guidance on the use of Mivacurium with respect to specific gender populations.

Race

There is no FDA guidance on the use of Mivacurium with respect to specific racial populations.

Renal Impairment

There is no FDA guidance on the use of Mivacurium in patients with renal impairment.

Hepatic Impairment

There is no FDA guidance on the use of Mivacurium in patients with hepatic impairment.

Females of Reproductive Potential and Males

There is no FDA guidance on the use of Mivacurium in women of reproductive potentials and males.

Immunocompromised Patients

There is no FDA guidance one the use of Mivacurium in patients who are immunocompromised.

Administration and Monitoring

Administration

There is limited information regarding Mivacurium Administration in the drug label.

Monitoring

There is limited information regarding Mivacurium Monitoring in the drug label.

IV Compatibility

There is limited information regarding the compatibility of Mivacurium and IV administrations.

Overdosage

There is limited information regarding Mivacurium overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

There is limited information regarding Mivacurium Pharmacology in the drug label.

Mechanism of Action

There is limited information regarding Mivacurium Mechanism of Action in the drug label.

Structure

There is limited information regarding Mivacurium Structure in the drug label.

Pharmacodynamics

There is limited information regarding Mivacurium Pharmacodynamics in the drug label.

Pharmacokinetics

There is limited information regarding Mivacurium Pharmacokinetics in the drug label.

Nonclinical Toxicology

There is limited information regarding Mivacurium Nonclinical Toxicology in the drug label.

Clinical Studies

There is limited information regarding Mivacurium Clinical Studies in the drug label.

How Supplied

There is limited information regarding Mivacurium How Supplied in the drug label.

Storage

There is limited information regarding Mivacurium Storage in the drug label.

Images

Drug Images

Package and Label Display Panel

Patient Counseling Information

There is limited information regarding Mivacurium Patient Counseling Information in the drug label.

Precautions with Alcohol

Alcohol-Mivacurium interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

There is limited information regarding Mivacurium Brand Names in the drug label.

Look-Alike Drug Names

There is limited information regarding Mivacurium Look-Alike Drug Names in the drug label.

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.


Linked-in.jpg